GUELPH, ON / ACCESSWIRE / November 6, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK) (TSXV:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has received a $1.1 million Government of Canada contract to test its multivalent aptamer technology for the rapid drug discovery of therapeutics or prophylactics of highly pathogenic avian influenza ("HPAI") A(H5N1). Highlights: The... Read More

GUELPH, ON / ACCESSWIRE / October 31, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK) (TSXV:ZEN), an intellectual property development and commercialization company announces that it has withdrawn its submission to the Health Canada Pest Management Regulatory Agency ("PMRA") for its ZenGUARD™ Enhanced Air Filters. Based on feedback received from PMRA, and continued analysis of the Canadian regulatory... Read More

GUELPH, ON / ACCESSWIRE / October 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK) (TSXV:ZEN), an intellectual property development and commercialization company, is pleased to provide an update on recent commercialization activities for its ZenGUARD™Antimicrobial Surgical Masks. As previously announced on July 24, 2024, the Company embarked on a Canada-wide sampling program for dental professionals... Read More

Guelph, Ontario--(Newsfile Corp. - September 26, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) (" Zentek " or the " Company "), an intellectual property development and commercialization company, announces the voting results from its annual and special meeting of shareholders (the " Meeting ") held on September 26, 2024. At the Meeting, shareholders voted in favour of all resolutions brought before the Meeting. Details of... Read More

Guelph, Ontario--(Newsfile Corp. - September 13, 2024) - Zentek Ltd. (NASDAQ: ZTEK) (TSXV: ZEN) (" Zentek " or the " Company ") announces that on September 11, 2024, it received a written notification (the " Notification Letter ") from the Nasdaq Stock Market LLC (" Nasdaq ") that the Company is not in compliance with Nasdaq Listing Rule 5550(a)(2), as the minimum bid price of the Company's common shares (" Shares ") has... Read More

GUELPH, ON / ACCESSWIRE / August 14, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSXV:ZEN) wishes to announce that, subject to regulatory approval, it will conduct a normal course issuer bid (the " Bid "). The Bid will be for up to 5,084,319 common shares of the Company over a period of one year (the " Bid Period "), being approximately 5% of Company's issued and outstanding common shares, with up to... Read More

GUELPH, ON / ACCESSWIRE / August 8, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce preliminary battery results and the commencement of a three-year, $441,000 project in collaboration with Professors Mohini Sain and Ning Yan from the University of Toronto ("U of T"). Funding for the project is... Read More

GUELPH, ON / ACCESSWIRE / July 24, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK) (TSXV:ZEN), an intellectual property development and commercialization company announces that it will embark on a Canada-wide sampling program for dental professionals facilitated by Henry Schein Inc. ("Henry Schein") that will see ZenGUARD™ Antimicrobial Surgical Masks included in product shipments to Henry Schein customers. In... Read More

GUELPH, ON / ACCESSWIRE / July 17, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK) (TSXV:ZEN), an intellectual property technology development and commercialization company is pleased to announce that its wholly owned subsidiary, Albany Graphite Corporation (AGC) has achieved a five nines purity of 99.99915% for a graphite sample from the Albany graphite deposit. Highlights Ultra-high purity "five nines"... Read More

GUELPH, ON / ACCESSWIRE / June 21, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK) (TSXV:ZEN) announces the granting of options to acquire an aggregate of 1,935,000 common shares to certain directors, officers and employees of the Company, exercisable at a price of $1.52 per common share for a period of five years from the date of the grant. For directors and officers, the options will vest one third on the... Read More

GUELPH, ON / ACCESSWIRE / May 27, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK) (TSXV:ZEN), an intellectual property technology development and commercialization company has received a second patent by the Canadian Intellectual Property Office titled: Graphene Oxide-Cationic Silver (GO-Ag+) Nanocomposites and Their Use as a Broad-Spectrum Antimicrobial Agent and includes a total of 64 successful claims.... Read More

GUELPH, ON / ACCESSWIRE / May 23, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK) (TSX-V:ZEN), an intellectual property development and commercialization company and DCL Supply Ltd. ("DCL Supply"), a private Heating, Ventilation and Air Conditioning ("HVAC") master product distributor are pleased to announce that they have entered into a distribution agreement effective March 19 th , 2024, for an initial... Read More

GUELPH, ON / ACCESSWIRE / May 7, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company is pleased to announce that it has completed a case study based on the City of Toronto highlighting the economic and environmental benefits related to using MERV 9A filters compared to using MERV 13 filters. The study quantifies cost savings and... Read More

GUELPH, ON / ACCESSWIRE / May 6, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK) (TSX-V:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has prioritized the development of a prophylaxis and therapeutic for highly pathogenic avian influenza ("HPAI") and reports initial test results. Background and Highlights: Universal aptamer has been selected for influenza virus, including... Read More

GUELPH, ON / ACCESSWIRE / May 3, 2024 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces the following changes to its board and management teams: (i) Dr. Francis Dubé has resigned as Chief Operating Officer of the Company effective May 1, 2024, and (ii) Brian Bosse has resigned as a director of the Company effective May 3, 2024, and... Read More

GUELPH, ON / ACCESSWIRE / April 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to provide an update on its ZenGUARD™ platform. The Company has made significant strides preparing for the launch of ZenGUARD™ Enhanced Air Filters for the Heating, Ventilation and Air Conditioning ("HVAC") market and pursuing new... Read More

GUELPH, ON / ACCESSWIRE / April 3, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce that it has entered into a definitive distribution agreement with Dallas, Texas-based Medwell Solutions LLC. ("MedWell") for its ZenGUARD TM Enhanced Surgical Masks in the U.S. The agreement was signed on March 18 th 2024 and is... Read More

GUELPH, ON / ACCESSWIRE / March 25, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK) (TSX-V:ZEN), announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera") has completed testing demonstrating that its C19HBA SARS-CoV-2 universal aptamer built on the proprietary high-binding affinity aptamer platform has shown a promising safety and toxicity profile in preclinical testing. This is a critical... Read More

GUELPH, ON / ACCESSWIRE / January 30, 2024 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK) (TSX-V:ZEN) announces that its wholly-owned subsidiary Triera Biosciences Ltd. ("Triera")has completed testing of its C19HBA aptamer as a potential therapeutic. The SARS-CoV-2 universal aptamer built on the proprietary high-binding affinity aptamer platform successfully outperformed a leading monoclonal antibody ("LMA") in... Read More

GUELPH, ON / ACCESSWIRE / January 22, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce the completion of a new study highlighting the potential significant energy, emission and cost savings for commercial buildings adopting ZenGUARD TM Enhanced Air Filters. As previously announced on February 6, 2023, and... Read More

GUELPH, ON / ACCESSWIRE / January 19, 2024 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that effective January 12th, Dr. Francis Dubé has resigned as Chairman of the Board of the Company in order to appoint an independent director, Mr. Eric Wallman as the Chairman of the Board as per best practices in governance. Mr.... Read More

GUELPH, ON / ACCESSWIRE / December 13, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company announces the launch of Triera Biosciences Ltd. (Triera) as Zentek's wholly owned subsidiary for its aptamer platform technology. As announced in the October 5 th , 2023, news release, this subsidiary now owns the exclusive, global... Read More

GUELPH, ON / ACCESSWIRE / December 8, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company and 1Click Heating and Cooling Inc. ("1Click"), a private Heating, Ventilation and Air Conditioning ("HVAC") company focused on the heat pump market are pleased to announce that they have signed a distribution agreement on December 7 th , 2023, for... Read More

GUELPH, ON / ACCESSWIRE / November 30, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK);(TSXV:ZEN), an intellectual property technology development and commercialization company announces the granting of 400,000 options total to a director and to an officer of the company exercisable at a price of $1.75 per common share with a term of three years for the officer and five years for the director from the date... Read More

GUELPH, ON / ACCESSWIRE / November 29, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company announces successful testing of its COVID-19 High-Binding Affinity (C19HBA) aptamer against the Omicron XBB 1.5 variant (Omicron) by the Miller Lab at McMaster University in the latest pre-clinical study. The performance of the C19HBA... Read More

GUELPH, ON / ACCESSWIRE / November 21, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company provides an update on its wholly owned subsidiary Albany Graphite Corp. On April 25 th , 2023, Zentek announced the intention to transfer its 100% owned, Albany Graphite Deposit, a rare hydrothermal graphite deposit located north of Lake Superior... Read More

GUELPH, ON / ACCESSWIRE / November 15, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company announces the development of a significant upgrade to its aptamer platform improving the binding affinity of the universal Covid-19 aptamer from 300 to over 500 times, compared to the base aptamer. The improved platform has also solved... Read More

GUELPH, ON / ACCESSWIRE / October 17, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company is pleased to announce completion of a study on the potential savings for the Canadian healthcare system from adopting ZenGUARD™-enhanced air filters. This analysis builds on the previously disclosed study announced on September 11, 2023, highlighting... Read More

Guelph, Ontario--(Newsfile Corp. - October 10, 2023) - Zentek Ltd. (Nasdaq: ZTEK) (TSXV: ZEN) (" Zentek " or the " Company "), an intellectual property development and commercialization company, announces voting results from the annual and special meeting of the Company's shareholders (the " Meeting ") held on October 5, 2023. At the Meeting, shareholders voted in favour of all resolutions brought before them. Details of all... Read More

GUELPH, ON / ACCESSWIRE / October 10, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce further successful pre-clinical testing of the aptamer-based platform technology by the Dr. Matthew Miller Lab. After initial promising results released on July 27 th , 2023, which featured an aptamer... Read More

GUELPH, ON / ACCESSWIRE / October 5, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company announces the launch of a wholly-owned subsidiary that will own the exclusive, global licensing rights for all aptamer-based technology from the collaboration with McMaster University. This licensing agreement includes the... Read More

GUELPH, ON / ACCESSWIRE / October 4, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company is pleased to provide a corporate update and recap of its ZenGUARD™ commercialization efforts and other aspects of its operations over the past several months. "Zentek has made significant strides on our ZenGUARD™ platform over the last number of months... Read More

GUELPH, ON / ACCESSWIRE / September 25, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company is pleased to announce its participation in BUILDEX Alberta 2023, Western Canada's largest exhibition and conference connecting the entire building industry. The event is scheduled to take place on October 18 & 19, 2023, at the Calgary TELUS... Read More

GUELPH, ON / ACCESSWIRE / September 21, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce its 2023 Annual General and Special Meeting will be held on Thursday, October 5th at 4:00 pm at the Delta Hotel in Guelph, Ontario. Capacity may be limited, and attendees must register by email at... Read More

GUELPH, ON / ACCESSWIRE / September 11, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property technology development and commercialization company is pleased to announce the successful results of a recent study conducted by ParticleOne, an RWDI Ventures company (" RWDI "). The study evaluated the performance of Zentek's ZenGUARD™-enhanced filter technology in comparison to a... Read More

GUELPH, ON / ACCESSWIRE / September 6, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property technology development and commercialization company is pleased to announce the results of a recent study comparing the Viral Filtration Efficiency ("VFE") of its ZenGUARD™-enhanced MERV 9 filters with an uncoated MERV 9 filter. The testing was performed by the third-party lab LMS... Read More

GUELPH, ON / ACCESSWIRE / August 24, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company has signed a Distribution and Supply Agreement with Henry Schein, Inc. (Henry Schein). This initial agreement will be for a period of three years and is for Canada and the United States. Sales of ZenGUARD™ surgical masks in the United States will... Read More

GUELPH, ON / ACCESSWIRE / July 27, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), a technology development and commercialization company and McMaster University (McMaster) are proud to announce that Dr. Yingfu Li and his team at the Li Lab have developed a novel aptamer technology that increases the binding affinity of aptamers by up to 250 times. The increased binding affinity enhances the limits of... Read More

GUELPH, ON / ACCESSWIRE / July 26, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce an updated Mineral Resource estimate for the Albany Graphite Project located north of Lake Superior and southwest of James Bay in Northeastern Ontario, which is owned by Zentek's wholly-owned subsidiary Albany Graphite Corp. ("... Read More

GUELPH, ON / ACCESSWIRE / July 20, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), a technology development and commercialization company, is pleased to announce, further to its press release dated May 19, 2022, that its aptamer platform under global exclusive license from McMaster University ("McMaster") has been successfully tested as a potential prophylactic or therapeutic for SARS-CoV-2 in... Read More

GUELPH, ON / ACCESSWIRE / July 13, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company, is pleased to announce updates to its senior management team. Mr. Colin van der Kuur has been promoted from Vice President, Science and Research to Chief Scientific Officer. Colin has been with Zentek since 2018 and has been instrumental in identifying... Read More

GUELPH, ON / ACCESSWIRE / June 29, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK);(TSXV:ZEN), a graphene technology development and commercialization company announces the filing of its audited consolidated financial statements for the financial year and quarter ended March 31, 2023 (the " 2023 Annual Financial Statements "). Over-Impairment of Albany Graphite Project As previously announced in its press... Read More

GUELPH, ON / ACCESSWIRE / June 22, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company has been awarded a research and development contract through Innovative Solutions Canada to test ZenARMOR™ nano-pigment in military grade, chromate-free, corrosion protection aerospace paint systems. The Company previously announced in its February 8 th ,... Read More

GUELPH, ON / ACCESSWIRE / June 1, 2023 / Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company announces that Ms. Lisa Sim has been appointed to the board of directors of Zentek as an independent director. Ms. Sim is a partner with Miller Thomson LLP and a member of their Executive Committee and has been listed in The Best Lawyers in Canada... Read More

GUELPH, ON / ACCESSWIRE / May 30, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company is pleased to announce a collaboration with Pattern Energy Group LP (" Pattern Energy ") to optimize, test and validate Zentek's icephobic coating for the wind turbine industry. The partnership is being supported financially by both the Natural Sciences and... Read More

GUELPH, ON / ACCESSWIRE / May 24, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), announces that, subject to regulatory approval, it will conduct a normal course issuer bid (the " Bid "). The Bid will be for up to 4,979,349 common shares of the Company over a period of one year (the " Bid Period "), being approximately 5% of Company's issued and outstanding common shares of the Company's issued and... Read More

GUELPH, ON / ACCESSWIRE / May 23, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), a graphene technology development and commercialization company is pleased to announce that further to its press release dated April 24, 2023, the Company has completed the transfer of the Albany Graphite Project (as defined below) to its wholly-owned subsidiary, Albany Graphite Corp. (" Albany ") pursuant to a Property... Read More

GUELPH, ON / ACCESSWIRE / May 18, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK) (TSXV:ZEN), a graphene technology development and commercialization company has been granted ISO 13485:2016 Quality Management System (QMS) certification standard by British Standards Institution (BSI). The company has also received Medical Device Single Audit Program (MDSAP) certificate # 777967. These certifications validate... Read More

GUELPH, ON / ACCESSWIRE / May 4, 2023 / Further to its press release dated September 19, 2022, Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK) (TSX-V:ZEN), a graphene technology development and commercialization company, reports successful drone testing, where thrust was maintained under calibrated icing conditions of freezing drizzle and freezing rain in an outdoor, real-world environment. The drone with Zentek's... Read More

GUELPH, ON / ACCESSWIRE / May 3, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ ZTEK)(TSXV: ZEN), a graphene technology development and commercialization company, further to its press release dated April 25, 2023 announcing the intention to transfer its Albany Graphite Project located north of Lake Superior and southwest of James Bay in Ontario to its currently wholly-owned subsidiary Albany Graphite Corp., provides... Read More

GUELPH, ON / ACCESSWIRE / April 25, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company is pleased to announce the execution of a property purchase agreement (the "Agreement") with its recently incorporated and currently wholly-owned subsidiary Albany Graphite Corp. ("Albany") to transfer the Albany Graphite Project, and the intention of... Read More

GUELPH, ON / ACCESSWIRE / April 14, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), a graphene technology development and commercialization company, announces the granting of 600,000 options to directors, officers and employees of the company exercisable at a price of $2.12 per common share for a period of three to five years from the date of the grant. The options will vest one-third on the date of... Read More

GUELPH, ON / ACCESSWIRE / April 5, 2023 / Zentek Ltd. ( "Zentek" or the "Company" ) (NASDAQ:ZTEK) (TSX-V:ZEN), a graphene technology development and commercialization company, has filed patent applications for ZenGUARD™ in 47 countries. The examiner for the Patent Cooperation Treaty, the international patent law treaty, that reviewed the ZenGUARD™ patent application opined that it met all 3 requirements to be granted a... Read More

GUELPH, ON / ACCESSWIRE / March 30, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK) (TSXV: ZEN), an intellectual property development and commercialization company, has signed an agreement (the "Agreement") with Arka BRENStech Pvt Ltd ("BRENStech"), a company incorporated under the laws of the Republic of India (India), pursuant to which BRENStech will act as a local partner to Zentek as it seeks to develop... Read More

GUELPH, ON / ACCESSWIRE / March 22, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK); (TSXV:ZEN), an intellectual property development and commercialization company, announces that SGS Standard Technical Services Co. ("SGS") recently conducted tests to determine the extent of the antimicrobial properties and the time required to achieve deactivation of bacteria and virus on ZenGUARD™-coated mask material. "Our... Read More

GUELPH, ON / ACCESSWIRE / March 17, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK; TSX-V:ZEN), an intellectual property development and commercialization company, announces its Chief Executive Officer, Greg Fenton, will present at the Industrial Tech Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on Tuesday, March 21, 2023. Mr. Fenton will participate in a virtual fireside chat at 2 p.m.... Read More

GUELPH, ON / ACCESSWIRE / March 3, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces that, pursuant to a review by the Ontario Securities Commission (the "OSC") of the Company's continuous disclosure, at the OSC's request, the Company has removed from its website reference to the material resource estimate for the Albany... Read More

GUELPH, ON / ACCESSWIRE / February 15, 2023 / Zentek Ltd. ("Zentek") (NASDAQ:ZTEK) (TSX-V:ZEN), an intellectual property development and commercialization company, and 1329307 BC Ltd. are pleased to announce that they have signed a non-binding letter of intent dated February 13, 2023 (the "LOI"), pursuant to which the parties have agreed to negotiate a transaction (the "Transaction") involving the transfer of Zentek's Albany... Read More

GUELPH, ON / ACCESSWIRE / February 8, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has developed ZenARMOR™, a novel corrosion protection technology based on functionalized Graphene Oxide (GO) that offers superior performance, self-healing properties and a potential environmental advantage. Corrosion is a costly issue that... Read More

GUELPH, ON / ACCESSWIRE / February 6, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce, further to its press releases dated April 11 2022 and December 15, 2022, that it has received the final report for Phase 2 testing of ZenGUARD™ for use in Heating, Ventilation and Air Conditioning ("HVAC") filtration from the... Read More

GUELPH, ON / ACCESSWIRE / January 19, 2023 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, has signed a Distribution Agreement with Southmedic Inc. ("Southmedic") for the distribution of Zentek's patented ZenGUARD™ surgical masks. Under the agreement, Southmedic will be the distributor of ZenGUARD™-enhanced surgical masks to the Canadian... Read More

GUELPH, ON / ACCESSWIRE / January 12, 2023 / Zentek Ltd. ("Zentek" or the "Company") (Nasdaq:ZTEK);(TSXV:ZEN), an intellectual property development and commercialization company, welcomes Mr. Mitch Swergold as its Director of Investor Relations. Mr. Swergold earned a Bachelor of Arts in Political Science from Columbia University in the City of New York, and a Juris Doctor degree from Emory University School of Law. After... Read More

GUELPH, ON / ACCESSWIRE / December 15, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, reports, further to its press release of April 11, 2022, the successful completion of Phase 2 HVAC filter testing by the National Research Council of Canada ("NRC"). The Company has received the preliminary report from Phase 2 testing under its... Read More

GUELPH, ON / ACCESSWIRE / December 7, 2022 / Zentek Ltd. ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property (IP) development and commercialization company, is pleased to announce that on December 6, 2022, it was granted Patent Number 3,152,759 for its ZenGUARD™ technology, "graphene-silver composites and uses for same as an antimicrobial composition." The patent was granted by the Canadian... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), announces that it has filed amended and restated audited financial statements (the " Amended and Restated Financials ") for the financial year ended March 31, 2022, which amend and restate the previously filed audited financial statements for the financial year ended March 31, 2022 (the " Financial Statements "). Part 3.2 of Companion Policy 51-102CP... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces the commencement of a 4-year, $1.6M research project in collaboration with Professors Mohini Sain and Ning Yan from the University of Toronto ("U of T") and Ford Powertrain Engineering Research and Development Centre ("PERDC") . Funding for the project includes $1.2M from the... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property ("IP") development and commercialization company, is pleased to announce that it was chosen to present the Company's ZenGUARD™ technology at the 12th Annual Global Summit on Regulatory Science on October 19-21, 2022, in the Innovative Nanotechnology Advancement in the Drug and Medical Device track. The theme of this year's summit,... Read More

Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces voting results from the annual and special meeting of the Company's shareholders (the " Meeting ") held on September 29, 2022. At the Meeting, shareholders voted in favour of all resolutions brought before them. Details of all resolutions that were voted upon are set out in the... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK); (TSXV:ZEN), an intellectual property (IP) development and commercialization company, is pleased to announce that on September 16, 2022, it's Canadian patent application directed to its ZenGUARD™ technology, for use on personal protective equipment ("PPE") , and heating, ventilation, and air conditioning ("HVAC"), has been allowed by the Canadian Intellectual Property... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that Greg Fenton, CEO, will hold investor meetings and present at this year's Sidoti Small-Cap Virtual Investor Conference, which will be held September 21-22, 2022. Mr. Fenton will deliver his corporate presentation on Thursday, September 22nd at 12:15 PM ET, and can be accessed... Read More

Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, has successfully completed sand erosion testing at the National Research Council ("NRC") in Ottawa and rain erosion testing at the Anti-icing Materials International Laboratory ("AMIL") in Quebec on Zentek's patent-pending Icephobic Coatings. These results, when taken with the strong... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, reports, further to its press release dated April 11, 2022, that it has received the final report from Phase 1 testing under its Innovation Solutions Canada ("ISC") Testing Stream contract, which notes that all Phase 1 targets were met including: (i) a sufficient reduction in live airborne... Read More

Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce its 2022 Annual General and Special Meeting will be held on Thursday, September 29th at 4:00 pm at the Delta Hotel in Guelph, Ontario. Capacity may be limited, and attendees must register by email at info@zentek.com . The meeting will be live streamed for those who... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK; TSX-V:ZEN), an intellectual property development and commercialization company, announces it has entered into a Manufacturing and Supply Agreement with Viva Healthcare Packaging (Canada) Ltd. (" VMedCare ") to manufacture and sell surgical masks enhanced with Zentek's proprietary ZenGUARD™ antimicrobial coating. During the pandemic, VMedCare quickly became one of the... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, provides the following updates on its commercial agreements relating to its proprietary ZenGUARD™ antimicrobial coating. Ekomed On April 12, 2022, the Company announced that it had entered into a Reciprocal Supply Agreement (the " Ekomed Agreement ") dated March 31, 2022, with EkoMed Global... Read More

Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK) (TSX-V:ZEN), an intellectual property development and commercialization company, has filed a provisional patent on the use of ZenGUARD™ as an anti-inflammatory agent for dermatological conditions. "We continue to work diligently to secure patents for our various intellectual property," said Greg Fenton, CEO for Zentek. "This is another demonstration of how we are... Read More

Zentek Ltd . ("Zentek" or the "Company") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, welcomes Ilse Treurnicht to its Board of Directors. Ms. Treurnicht holds a DPhil in chemistry from Oxford University in the United Kingdom, which she attended as a Rhodes Scholar. Ms.Treurnicht is Managing Partner of TwinRiver Capital, an impact investment firm focused on advancing positive... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce that on March 28, 2022, the Canadian national phase was initiated for its patent application directed to its ZenGUARD™ technology. Zentek's patent strategy typically begins by filing one or more provisional patent applications with the United States Patent and... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, is pleased to announce the grand opening of its industrial scale ZenGUARD™ antimicrobial production facility in Guelph, Ontario on Friday June 17 th , 2022, at 2:00 pm. This facility is one of the largest nanomaterials-based manufacturing facilities in the world. "The opening of this... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK; TSX-V:ZEN), an intellectual property development and commercialization company, is pleased to announce that McMaster University (" McMaster ") has received two Natural Sciences and Engineering Research Council (" NSERC ") Grants related to the aptamer-based rapid detection technology exclusively licensed by Zentek pursuant to its licence agreement dated April 11, 2021... Read More

Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK)(TSX-V:ZEN), an intellectual property development and commercialization company, announces that Wendy Ford has been appointed as the new Chief Financial Officer (" CFO ") for the organization. Ms. Ford has more than three decades of experience in finance and accounting leadership roles for both private and publicly traded companies. Brian Bosse will transition from his... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK)(TSXV:ZEN), an intellectual property development and commercialization company, announces that Mark's, a member of the Canadian Tire Family of Companies, has placed an initial order for ZenGUARD™ coated-masks to be sold at select stores across Canada, and online. Mark's is an innovative Canadian clothing and footwear retailer specializing in casual, industrial and... Read More

Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK; TSX-V:ZEN), a Canadian intellectual property development and commercialization company, announces it has engaged The Benchmark Company, LLC (" Benchmark ") to act as strategic financial advisor with respect to potential transactions relating to its Albany Graphite Deposit in Northern Ontario. "As the potential for a robust graphene market grows along with the strong... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK) (TSX-V:ZEN), a Canadian intellectual property development and commercialization company, announces it has signed a definitive supply agreement with EkoMed Global Inc. (" EkoMed "), a globally integrated manufacturer and distributor of personal protective equipment (" PPE "), pursuant to which (i) Zentek will sell quantities of its proprietary ZenGUARD™ coating to... Read More

Further to its press release dated November 30, 2021, Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK) (TSX-V:ZEN), a Canadian intellectual property development and commercialization company, announces that after successful completion of Phase 1 testing of its ZenGUARD™-coated HVAC filters, it will proceed to Phase 2 testing within its Innovation Solutions Canada ("ISC") Testing Stream contract. Pursuant to its... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK) (TSX-V:ZEN), a Canadian intellectual property development and commercialization company, announces its partnership with FTI Consulting (Government Affairs), LLC ("FTI"), a Washington, D.C. based global advisory firm, to support its efforts to bring ZenGUARD™ and its other technologies to the U.S. "Zentek's partnership with FTI will help the Company expand its presence... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK; TSX-V:ZEN), a Canadian intellectual property development and commercialization company, has filed a provisional patent with the United States Patent and Trademark Office for an innovative Graphene Oxide-Metal-Organic Framework (GO-MOF) compound for use in fire retardant products. The compound contains only components that are generally considered environmentally... Read More

Zentek Ltd. (" Zentek " or the " Company ") (Nasdaq:ZTEK) (TSX-V:ZEN), a Canadian intellectual property development and commercialization company, is pleased to announce that its international patent application for its Zen GUARD ™ technology has been published by the World Intellectual Property Office. "This demonstrates our company's ability to complete the journey from scientific breakthrough to commercialization," said... Read More

Zentek Ltd. (" Zentek " or the " Company ") (NASDAQ:ZTEK; TSX-V:ZEN; and OTC PINK:ZENYF), a Canadian intellectual property development and commercialization company, is pleased to announce that its SEC Form 40-F registration statement will be effective at the close of business today, and that its common stock has been approved and will commence trading on the Nasdaq Capital Market ("Nasdaq") under the symbol "ZTEK" on... Read More

Zentek Ltd. (" Zentek " or the " Company ") (TSX-V:ZEN and OTC:ZENYF), a Canadian IP (Intellectual Property) development and commercialization company, is pleased to report excellent results in three rounds of testing of its icephobic coating, including laboratory tests, real-world flights and applications related to drone operations in adverse weather. To support this effort, Zentek has undertaken UV weathering testing to... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian IP (Intellectual Property) development and commercialization company focused on next-gen healthcare solutions, today announces that it has retained Vimta Labs Limited ("Vimta"), a leading clinical research organization in India, to begin studies of ZEN's Zen GUARD ™ active ingredient as a potential treatment of infectious skin disease. Vimta... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN and OTC PINK:ZENYF), wants to clarify that the technology utilized in its ZenGUARD™ antimicrobial coating was developed exclusively by ZEN at its facility in Guelph, Ontario during the summer of 2020. Zentek's ZenGUARD™ technology does not use any of the technology related to the claim made in the patent applications of Graphene Composites Ltd. ("GC"). As disclosed March 8,... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions has become aware of certain rumours and allegations being circulated, and categorically refutes the egregious allegation regarding the theft of intellectual property from Graphene Composites Ltd. On January 29, 2021, the Company was served with a statement... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, today announces the addition of Mr. Ravi Kaza to its Advisory Board. Mr. Kaza graduated from The Wharton School of the University of Pennsylvania with a BS in Finance Summa Cum Laude at age 19 and has spent the last 25 years consistently focused on disruptive... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, today announces that it has received approval to have its common stock listed on the Nasdaq Capital Market ("Nasdaq") under the symbol ZTEK. Zentek's common stock will continue to trade on the TSX Venture Exchange (TSX-V) under the symbol ZEN. The Company... Read More

LATEST GRAPHITE STOCK NEWS Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN) and (OTC:ZENYF), an IP development and commercialization company focused on next-gen healthcare solutions, announces that Chief Executive Officer Greg Fenton will present at the Sidoti & Company Virtual Small Cap Conference being held from January 19 - 20, 2022. Mr. Fenton will deliver his corporate presentation on Thursday, January 20, 2022, at 9:15 AM ET, and can be... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), an IP development and commercialization company focused on next-gen healthcare solutions, announces the granting of 1,300,000 options to directors, officers and employees of the company exercisable at a price of $4.25 per common share for a period of three to five years from the date of the grant. The options will vest one-third on the date of grant,... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, is pleased to announce that it has entered into a binding letter of intent (the " LOI ") with GMAF Circular Medico ApS (" GMAF ") to produce and sell ZEN Guard™-enhanced GMAF trademarked recyclable surgical masks (" Circular PPE ™"). As previously announced in... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN and OTC:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, is pleased to announce that it has commenced receiving direct retail orders for ZEN Guard™-enhanced surgical masks under its Medical Device Establishment License (" MDEL ") recently issued by Health Canada, further to the Company's press release dated November... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, IP development and commercialization company focused on next-gen healthcare solutions, today announces it has been awarded an R&D test contract through the Innovation Solutions Canada (ISC) Testing Stream Call for Proposals to test ZEN Guard™-coated HVAC filters with interest from 3 different units within the National Research Council of Canada... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN and OTC:ZENYF), a Canadian, IP development and commercialization company focused on next-gen healthcare solutions, today announces it has been issued a Medical Device Establishment License ("MDEL") from Health Canada (license number 18823) for the manufacture and distribution of class one medical devices. This will allow the Company to begin working with other manufacturers... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN and OTC:ZENYF), is pleased to announce that, further to the news release of November 16, 2021, the Company has filed a preliminary prospectus dated November 22, 2021 in order to qualify the distribution of 5,129,944 common shares of the Company (the " Common Shares ") at a purchase price of $5.85 per Common Share (the " Offering Price ") for aggregate gross proceeds of... Read More

Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC:ZENYF) a Canadian, IP development and commercialization company focused on next-gen healthcare solutions announces that it has entered into an agreement with Eight Capital as lead underwriter and sole bookrunner on behalf of a syndicate of underwriters (collectively, the “ Underwriters ”), pursuant to which the Underwriters have agreed to purchase on a bought deal basis... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian, IP development and commercialization company focused on next-gen healthcare solutions, today announces the following corporate updates: Supply Chain In response to the challenges facing global supply chains, Zentek has reached an agreement to secure the necessary supply of graphene oxide (GO) to produce enough ZEN Guard™ to coat the... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian IP development and commercialization company focused on next-gen healthcare solutions, is pleased to provide an update on its leading-edge rapid detection platform: ZEN has contracted NeoVentures Biotechnology Inc. - a world leader in aptamer development and applications - which has validated the McMaster results against spike proteins and is... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN) (OTC PINK:ZENYF), a Canadian, IP development and commercialization company focused on next-gen healthcare solutions, announces it has been selected as one of three technologies for phase 1 of the Innovation Solutions Canada (ISC) challenge to develop a portable detection device for SARS-CoV-2 in wastewater. ZEN has received a $148,000 award from ISC to develop its first... Read More

Company anticipates applications for aircraft, wind turbines, ocean vessels, and building structures to increase safety and efficiency outcomes in ice-forming weather conditions Zentek Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, IP development and commercialization company focused on next-gen healthcare solutions, announces the development of a new, patent-pending, carbon-based,... Read More

Zentek Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, IP development and commercialization company focused on next-gen healthcare solutions, today announces it has added to its management team and Advisory Board to help drive forward the company's execution on its business plans. Management Vivian Martin - Director, Regulatory Affairs - Vivian brings more than a decade of regulatory affairs... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian, intellectual property development company focused on next-gen healthcare solutions, is pleased to announce that it has filed articles of amendment to change its name to "Zentek Ltd." (the " Name Change "). The Name Change was approved by shareholders of the Company at its annual and special meeting held on September 27, 2021.... Read More

ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN) and (OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces today that Chief Executive Officer, Greg Fenton will present a corporate overview at the Benzinga Global Small Cap Conference, which is being held virtually on October 27 - 28, 2021. Mr. Fenton will deliver his corporate presentation on Wednesday, October... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN and OTC:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, is pleased to announce that, further to its press release dated August 26, 2021, it has received final approval from the TSX Venture Exchange ("TSXV") to change its classification on the TSXV from a "mining issuer" to an "industrial, technology, or life sciences... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces that it has submitted an application to list its common stock on The Nasdaq Capital Market ® ("Nasdaq") and that it has retained Donohoe Advisory Associates LLC to assist with the listing process. The listing of the Company's common shares on the Nasdaq... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces that it has filed a full international patent application for its ZEN Guard™ compound under the Patent Cooperation Treaty (PCT). The company elected to file an international patent due to the global opportunities for its technology. "We believe our ZEN... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF) gives notice of accelerated expiry to the holders of 760,848 common share purchase warrants ("2021 Warrants") of the Company, which were issued pursuant to a private placement completed on April 8, 2021 and 1,419,753 warrants (the "2020 Warrants") of the Company which were issued pursuant to a private placement completed on July 6, 2020.... Read More

Company receives shareholder support to transition toward its nanotechnology and health sciences focus Retains CORE IR for investor relations, public relations, U.S. listing advisory and capital markets advisory ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, today announces that shareholders have approved all... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces that it has signed a definitive commercial agreement with Trebor Rx (Trebor) for the manufacturing of ZEN Guard™-enhanced personal protective equipment. The agreement includes surgical masks, filters for Trebor's patent pending Pro+ mask, nitrile gloves... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, announces test results demonstrating significantly enhanced bacterial filtration efficiency (BFE) and viral filtration efficiency (VFE) of ZEN Guard™-enhanced surgical masks. The ZEN Guard™ coated masks removed 98.9% more bacteria and 97.8% more virus particles... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, today announces that it has delivered and generated revenue from its first shipment of ZEN Guard TM antimicrobial coating to Trebor Rx (Trebor). This first commercial shipment was enabled by a successful ramp up from bench scale production to pilot scale... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, today announces Health Canada approval of ZEN Guard™ disposable face mask with biocidal coating and is rated at an ASTM Level 3. The review process included extensive examination of data related to shedding, inhalation safety, skin irritation, pathogen... Read More

ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSX-V:ZEN)(OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, is pleased to announce that Chief Executive Officer, Greg Fenton will present at the Sidoti Fall Virtual Investor Conference, which is being held September 22 - 23, 2021. Mr. Fenton will deliver his corporate presentation on Thursday, September 23 at 8:30 AM ET, and... Read More

ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, would like to notify shareholders that have registered and received confirmations that they are welcome to attend the Company's Annual General Meeting (AGM) of shareholders on September 27, 2021. Due to COVID-19 and its threat to the community, we are required to... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) and (OTC PINK:ZENYF), ) announces stock option grants for two employees. These options are exercisable for an aggregate of 100,000 common shares at an exercise price of $3.69 per common share for a period of three years from the date of the grant which will vest one-third on the date of grant, one-third after six months of the date of grant and one-third... Read More

ZEN Graphene Solutions Ltd. (“ ZEN ” or the “ Company ”) (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, is pleased to announce the 2021 Shareholder Meeting will be held on Monday, September 27 th at 4pm at the Delta Hotel in Guelph, Ontario. Due to COVID-19, capacity will be limited to the first 50 shareholders who register by email at info@zengraphene.com.... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, nanotechnology company focused on next-gen healthcare solutions, is pleased to announce that it has made an application to change its classification on the TSX Venture Exchange ("TSXV") from a mining issuer to an industrial, technology, life sciences issuer. Given the Company's focus on commercializing nanotechnology-enabled,... Read More

ZEN Graphene Solutions (TSXV: ZEN) today announced that Dr. Francis Dube, Executive Chair will be attending the Q3 Virtual Investor Summit. Event Q3 Investor Summit Date August 17-18th, 2021 Presentation August 18th at 8:45AM ET Location https://zoom.us/webinar/register/WN_Mt_sG54lRg2JoK-vzA8ctA About ZEN Graphene Solutions ZEN is a nanotechnology company developing and commercializing next-gen healthcare solutions in the... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) and (OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is pleased to announce that Dr. Kenneth Reed, Medical Director at DermASAP, will join the ZEN Advisory Board effective immediately. Dr. Reed, a Harvard Medical School trained dermatologist, has 38 years of clinical experience in the state of Massachusetts. Dr. Reed will devote... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is pleased to announce that it has signed an exclusive agreement with McMaster University to be the global commercializing partner for a newly developed aptamer-based, SARS-CoV-2 rapid detection technology, developed by a team of researchers under the guidance of Drs. Yingfu Li, John... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company and Trebor Rx Corp. (Trebor) are pleased to provide an update on the Health Canada review process for the ZEN Guard TM -enhanced, ASTM level 3 surgical mask. ZEN has been advised by Trebor that it received a response letter from Health Canada indicating that more information was required... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company and Trebor Rx Corp. (Trebor) are pleased to announce successful inhalation safety testing results of ZEN Guard TM -enhanced surgical masks and submission of these results to Health Canada. Testing was completed by NanoSafe Inc. (NanoSafe) in Blacksburg, Virginia confirmed that no ZEN... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is pleased to announce that it has developed a stable diesel fuel additive, which increased the performance of diesel fuel by up to 10% in initial testing. These tremendous early results can be improved further through additional optimization work. ZEN has filed a provisional patent for... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN and OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is pleased to announce that it will begin an ingestion Good Laboratory Practice (GLP) compliant safety study of its patent-pending, graphene-based compound following successful testing against Clostridium Difficile (C. Difficile) at the University of Manitoba under the supervision of... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSX.V:ZEN) (OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is pleased to provide an update on the following: Health Canada (HC) Submission - Additional information requested by Health Canada following the April 2 advisory has been submitted by ZEN and Trebor RX Corp (Trebor) Branding - Trademark application has been submitted and ZEN will... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) and (OTC PINK:ZENYF), a Canadian, next-gen nanomaterials technology company, is aware of the statements from Health Canada (HC) regarding masks containing graphene and is aligned and supportive of the steps taken to regulate the use of graphene and remove products that are unsafe for the public. ZEN has had comprehensive testing performed on its biocidal... Read More

ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSX Venture Exchange:ZEN) is pleased to announce, in connection with its previously announced non-brokered private placement (the "Offering"), and previous upsizing, that due to very strong demand the Company has increased the size of the Offering to up to 2,000,000 units (the "Units") at a price of CDN$2.50 per Unit for gross proceeds of up to CDN$5,000,000. The private... Read More

ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN) is pleased to announce, in connection with its previously announced non-brokered private placement (the "Offering"), that due to strong demand the Company has increased the size of the Offering to up to 1,600,000 units (the "Units") at a price of CDN$2.50 per Unit for gross proceeds of up to CDN$4,000,000. The company will close the private placement... Read More

ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN) is pleased to announce, in connection with its previously announced non-brokered private placement (the "Offering"), that due to higher demand the Company intends to increase the size of the Offering to up to 1,400,000 units (the "Units") at a price of CDN$2.50 per Unit for gross proceeds of up to CDN$3,000,000. Each Unit will consist of one common share in the... Read More

ZEN Graphene Solutions Ltd. ("ZEN" or the "Company") (TSXV:ZEN) announces an offering (the "Offering") of units (the "Units") of the Company on a non-brokered private placement basis, for gross proceeds of up to $2,000,000, at a price of $2.50 per Unit. The Offering is subject to TSX Venture Exchange (the "Exchange") approval. Each Unit will be comprised of one Common Share of the Company and one-half of one Common Share... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN)(OTC Pink:ZENYF), a next-gen nanomaterials technology company, is pleased to announce its preliminary biocidal coating production plan to meet the strong demand in the personal protective equipment (PPE) and air filtration markets. ZEN successfully transitioned from bench scale to pilot scale and has begun investing in additional pilot-scale capacity to help... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) and (OTCPINK:ZENYF), a next-gen nanomaterials technology company, is pleased to announce successful testing results of its patent-pending graphene-based compound against four gram-positive and nine gram-negative bacteria with antimicrobial-resistance (AMR), including multidrug-resistant variants like methicillin-resistant staphylococcus aureus (MRSA).... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN)(OTC Pink:ZENYF) is pleased to announce further steps in collaboration with Constance Lake First Nation (CLFN) led by Chief Rick Allen. Pursuant to the July 13, 2011, Exploration Agreement, the July 19, 2018, Memorandum of Understanding and subsequent September 24, 2018 amendment, both parties have now signed an Implementation Agreement (IA). The IA sets out... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC Pink:ZENYF), a next-gen nanomaterials technology company, is pleased to announce it has been advised by Trebor Rx Corp. (Trebor) that their surgical masks with ZEN's biocidal coating have passed Health Canada testing requirements as a level 2 medical device. The coated masks were tested at a Health Canada approved facility in line with American Society... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a next-gen nanomaterials technology company, is pleased to announce successful phase 2 results from cytotoxicity testing of its graphene-based compound. Nucro-Technics recorded no adverse effects after seven days of repeated dosing with concentrations many thousands of times higher than those found to be 99.9% effective against viruses,... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSXV:ZEN) (OTC PINK:ZENYF), a next-gen nanomaterials technology company, is pleased to announce that it has been recognized as a Venture 50 company by the TSX Venture Exchange for 2020. The TSX Venture 50 is a ranking of the top performers on the TSX Venture Exchange over the last year based on three equally weighted criteria: market capitalization growth, share price... Read More

ZEN Graphene Solutions Ltd. (" ZEN " or the " Company ") (TSX-V:ZEN) and (OTC:ZENYF) is pleased to announce very promising initial phase 2 results of the 7-day repeated dose safety testing from Nucro Technics for potential human pharmaceutical use of its graphene-based compound. Dr. Francis Dubé, ZEN Executive Chairman, commented: "The company continues to make positive progress towards our patent-pending, biocidal compound... Read More